Video Experimental Relacionado
Updated: Jun 11, 2026
11:56
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Las estructuras de los antibióticos MLSBK unidos a grandes subunidades ribosómicas mutadas proporcionan una
Daqi Tu1, Gregor Blaha, Peter B Moore
1Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06520, USA.
Cell
|April 27, 2005
Resumen
Las mutaciones en los ribosomas bacterianos, como G2099A, confieren resistencia a los antibióticos macrólidos al alterar la unión del fármaco. Comprender estos cambios estructurales explica los mecanismos de resistencia a los antibióticos en las bacterias.
Área de la Ciencia:
- Biología Estructural Biología estructural.
- Microbiología Microbiología.
- La bioquímica es la bioquímica.
Sus antecedentes:
- La resistencia a los antibióticos es una creciente preocupación para la salud mundial.
- Los antibióticos macrolides son cruciales para el tratamiento de infecciones bacterianas.
- Las mutaciones ribosomales pueden conferir resistencia a los antibióticos.
Objetivo del estudio:
- Para aclarar las bases estructurales de la resistencia a los antibióticos en los ribosomas bacterianos.
- Para explicar la unión diferencial de los macrólidos y otros antibióticos a las subunidades ribosómicas mutadas.
Principales métodos:
- Se utilizó la cristalografía de rayos X para determinar las estructuras de las subunidades ribosómicas mutadas con antibióticos unidos.
- Se realizó un análisis estructural comparativo para comprender las interacciones fármaco-ribosoma.
Principales resultados:
- La mutación G2099A en H. marismortui (A2058G en E. coli) altera significativamente la unión de los macrólidos, en particular para la eritromicina, lo que explica la resistencia.
- La unión de la azitromicina se ve afectada mínimamente por la mutación, mientras que la afinidad de la eritromicina aumenta sustancialmente debido a los efectos de desolución.
- La unión sinérgica de las estreptograminas A y B implica la reorientación de la base ribosómica A2103 (A2062 en E. coli).
- Una mutación de deleción en la proteína ribosómica L22 altera la forma del túnel de salida, lo que contribuye a la resistencia a los macrólidos.
Conclusiones:
- La estructura ribosómica y las mutaciones específicas son determinantes clave de la eficacia de los antibióticos macrólidos.
- Comprender estas relaciones estructural-funcionales puede guiar el desarrollo de nuevos antibióticos y estrategias para combatir la resistencia.
Videos de Conceptos Relacionados
01:23Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...